Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
93,003,458
-
Share change
-
-809,186
-
Total reported value
-
$10,720,376,398
-
Put/Call ratio
-
93%
-
Price per share
-
$115.22
-
Number of holders
-
570
-
Value change
-
-$150,384,737
-
Number of buys
-
294
-
Number of sells
-
284
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2024
As of 30 Sep 2024,
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by
570 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,003,458 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Bellevue Group AG, GEODE CAPITAL MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, and JPMORGAN CHASE & CO.
This page lists
570
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.